论文信息 - Immunotherapy in Rasmussen’s encephalitis: when should it be taken into account? - 字舞流文

Immunotherapy in Rasmussen’s encephalitis: when should it be taken into account?

A. Spalice | P. Iannetti | L. Papetti | F. Nicita | F. Ursitti

[1] R. Dingledine,et al. The role of inflammation in epileptogenesis , 2013, Neuropharmacology.

[2] R. Guerrini,et al. Early add-on immunoglobulin administration in Rasmussen encephalitis: the hypothesis of neuroimmunomodulation. , 2011, Medical hypotheses.

[3] G. Avanzini,et al. Immune‐mediated epilepsies , 2011, Epilepsia.

[4] F. Vigevano,et al. Epileptic encephalopathy in children possibly related to immune-mediated pathogenesis , 2010, Brain and Development.

[5] J. Schramm,et al. Treatment of Rasmussen encephalitis half a century after its initial description: Promising prospects and a dilemma , 2009, Epilepsy Research.

[6] C. Elger,et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. , 2005, Brain : a journal of neurology.

[7] G. Broggi,et al. Experience with immunomodulatory treatments in Rasmussen’s encephalitis , 2003, Neurology.